Stockscreener 앱 받기
10.86
1.50%
0.16
시간 외 거래:
10.86
전일 마감가:
$10.70
열려 있는:
$10.45
하루 거래량:
1.03M
Relative Volume:
0.49
시가총액:
$1.32B
수익:
-
순이익/손실:
$-29.07M
주가수익비율:
-37.45
EPS:
-0.29
순현금흐름:
$-31.85M
1주 성능:
+3.13%
1개월 성능:
+9.92%
6개월 성능:
+55.36%
1년 성능:
+257.24%
1일 변동 폭
$10.45
$10.98
1주일 범위
$10.30
$11.83
52주 변동 폭
$2.36
$11.83
트레비 테라퓨틱스 Stock (TRVI) Company Profile
명칭
Trevi Therapeutics Inc
전화
203-304-2499
주소
195 CHURCH STREET, NEW HAVEN, CT
TRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
10.86 | 1.30B | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 재확인 | Needham | Buy |
| 2025-03-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-30 | 개시 | Raymond James | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-12 | 개시 | B. Riley Securities | Buy |
| 2022-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | BMO Capital Markets | Outperform |
| 2019-06-03 | 개시 | Needham | Buy |
| 2019-06-03 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | Stifel | Buy |
모두보기
트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference - Stock Titan
Is now a turning point for Trevi Therapeutics Inc.Portfolio Gains Report & Risk Controlled Daily Plans - newser.com
Trevi Therapeutics Approaches Critical Financial Update - AD HOC NEWS
Historical volatility pattern of Trevi Therapeutics Inc. visualizedPortfolio Return Report & Real-Time Buy Zone Alerts - newser.com
Is Trevi Therapeutics Inc. stock a buy for dividend growth2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Technical signs of recovery in Trevi Therapeutics Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - newser.com
Using Bollinger Bands to evaluate Trevi Therapeutics Inc.2025 Dividend Review & Community Driven Trade Alerts - newser.com
TRVI (Trevi Therapeutics) Issuance of Stock : $0.00 Mil (TTM As of Jun. 2025) - GuruFocus
Momentum divergence signals in Trevi Therapeutics Inc. chartJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Applying sector rotation models to Trevi Therapeutics Inc.July 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
Should I hold or sell Trevi Therapeutics Inc. stock in 2025Weekly Trade Report & Technical Confirmation Trade Alerts - newser.com
What MACD signals say about Trevi Therapeutics Inc.Quarterly Investment Review & Intraday High Probability Alerts - newser.com
Will Trevi Therapeutics Inc. stock continue upward momentumJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Does Trevi Therapeutics Inc. show high probability of reboundWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Can Trevi Therapeutics Inc. stock reach $100 price targetWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
What high frequency data says about Trevi Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Analyzing drawdowns of Trevi Therapeutics Inc. with statistical tools2025 Top Decliners & Daily Entry Point Alerts - newser.com
Trevi Therapeutics Stock Soars on Clinical Progress and Institutional Backing - AD HOC NEWS
Trevi Therapeutics (NASDAQ:TRVI) Hits New 12-Month HighWhat's Next? - MarketBeat
Trevi Therapeutics stock hits all-time high at 11.11 USD By Investing.com - Investing.com India
Trevi Therapeutics stock hits all-time high at 11.11 USD - Investing.com
Trevi Therapeutics (TRVI) Projected to Post Earnings on Wednesday - MarketBeat
트레비 테라퓨틱스 (TRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):